MedCity News
JULY 5, 2024
In our eagerness for innovation, there’s a risk that we ignore existing effective, readily-available treatments. The post Why Wait? The Urgency of Accessible PTSD Treatments Now appeared first on MedCity News.
European Pharmaceutical Review
JULY 5, 2024
Following the Labour Party’s win yesterday in the UK 2024 General Election, industry representatives have voiced their opinions on what this could mean for the future of the pharmaceutical industry under the new government. Association of the British Pharmaceutical Industry (ABPI) The new government now needs to hit the ground running and rapidly set out a clear, detailed plan” “During its campaign, Labour was right to single out the UK’s life sciences sector as a critical partner fo
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JULY 5, 2024
When someone is sick or worried about an ailing loved one, they are already under stress. A good digital wayfinding experience can reduce that strain. The post True Blue-Dot Navigation in Healthcare is Both Harder and More Important Than You Think appeared first on MedCity News.
Pharmaceutical Technology
JULY 5, 2024
Fucaso, a BCMA CAR T-cell therapy, is co-developed by Innovent and IASO Bio and was approved to treat multiple myeloma in China last month.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
pharmaphorum
JULY 5, 2024
Reports indicate that private equity firms Bain Capital and Cinven may be contemplating a bid for the consumer health division of Sanofi.
Pharmaceutical Technology
JULY 5, 2024
Approval is based on positive data from the Phase III FLAURA2 trial where Tagrisso plus chemotherapy showed PFS of 24.4 months.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
JULY 5, 2024
After Labour landslide in UK general election, former shadow health secretary West Streeting sets out his objectives for the NHS.
PharmaTimes
JULY 5, 2024
Pneumococcus is the leading cause of pneumonia, meningitis and sepsis worldwide
PharmaTech
JULY 5, 2024
Shawn Davis, CEO of Liberate Bio, shares some insights into the world of drug discovery, development, and delivery, as well as process optimization
MedTechVets
JULY 5, 2024
JUL 6TH – We were proud to interview MedTechVet Traing Program Mentor, Scott Nelson. Scott is currently the Marketing Strategist for Wound Management and Surgical Reconstruction at LifeNet Health. Veterans have so much to offer but often limit their self-promotion which makes entering an entirely new industry very difficult. Our med tech space would benefit so much from these transitioning members that have incredible skills and experience.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmExec
JULY 5, 2024
In an interview with Pharm Exec Associate Editor Don Tracy, Kathy Lee-Sepsick, Founder, CEO, Femasys, offers a description of how Femaseed works to support women who struggle with infertility.
Pharmaceutical Technology
JULY 5, 2024
BioSenic and Medsenic filed patent application with the USPTO to extend the protection for the use of arsenic trioxide (ATO) for sepsis.
PharmaTech
JULY 5, 2024
Although advancements in analytical drug substance testing are being made, the increasing diversity of the therapeutic landscape is necessitating further innovation.
Pharmaceutical Technology
JULY 5, 2024
The UK life science industry is crossing its fingers as a Labour government takes the reigns following 14 years of Conservative rule.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
PharmExec
JULY 5, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
JULY 5, 2024
Whilst Regeneron and Sanofi secured approval in Europe for COPD, the FDA has delayed Dupixent’s application review for the disease in the US.
Pharmaceutical Commerce
JULY 5, 2024
An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.
Pharmaceutical Technology
JULY 5, 2024
The EMA has validated Philogen and Sun Pharmaceutical’s marketing authorisation application (MAA) for Nidlegy, a treatment for melanoma.
Pharmaceutical Commerce
JULY 5, 2024
An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.
Pharmaceutical Technology
JULY 5, 2024
The UK took to the polls on 4 July 2024 and voted in a new government. How will a Labour government look for the clinical trial sector?
Pharmaceutical Commerce
JULY 5, 2024
The latest news for pharma industry insiders.
Pharmaceutical Technology
JULY 5, 2024
As the UK transitions into a Labour party government, the pharma industry urges for boosted investment and talent attraction.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmacy Times
JULY 5, 2024
Pharmacists can play a crucial role in diabetes management by implementing standing order protocols for medication titration and serving as a bridge between patients and other health care providers.
Pharmaceutical Technology
JULY 5, 2024
SL-APO is marketed by Bial in France, Germany, Spain and the UK for the on-demand treatment of leveodopa wear-off.
Pharmacy Times
JULY 5, 2024
Vitamin D could mitigate negative impacts on neurobehavior and weight gain caused by consumption of monosodium glutamate (MSG).
Pharmaceutical Technology
JULY 5, 2024
HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer).
Pharmacy Times
JULY 5, 2024
Alan Chin, PharmD, BCOP, presents an overview of the most prevalent and common adverse reactions associated with EGFR-targeted therapies in metastatic NSCLC and shares strategies to mitigate toxicities, with a focus on managing dermatologic events such as rash and itching.
Pharmaceutical Technology
JULY 5, 2024
CTX-310 is under clinical development by CRISPR Therapeutics and currently in Phase II for Heterozygous familial hypercholesterolemia (heFH).
Pharmacy Times
JULY 5, 2024
A pharmacy expert explores infusion-related reactions associated with amivantamab, providing guidance on managing and preventing these reactions, while also addressing the role of split-dosing, premedications, and steroids in the treatment paradigm.
Pharmaceutical Technology
JULY 5, 2024
CTX-310 is under clinical development by CRISPR Therapeutics and currently in Phase II for Homozygous Familial Hypercholesterolemia (HoFH).
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
108 
Let's personalize your content